Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis

NCT01476956 is registered in ClinicalTrials.gov with CARE ARTHRITIS LTD. as lead sponsor.

NCT NCT01476956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01476956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis
Lead sponsor
CARE ARTHRITIS LTD.
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2019
Enrollment
571 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis